- AliveCor, a Mountain View, CA-based AI-based personal ECG technology and provider of enterprise cardiology solutions, raised $65m in Series E financing
- The round was led by existing investors OMRON, Khosla Ventures, WP Global Partners, Qualcomm Ventures, and Bold Capital Partners
- The company intends to use the funds to accelerate the growth of its remote cardiology platform both domestically and around the world
- AliveCor provides the FDA-cleared KardiaMobile device, a clinically validated personal ECG solution that provides instant detection of atrial fibrillation, bradycardia, tachycardia
- AliveCor’s enterprise platform allows third-party providers to manage their patients and customers’ heart conditions
- To date, the company’s products have served more than one million customers around the world and recorded more than 85 million ECGs
AliveCor: Closes $65M Series E Funding Round
